Modulated inflammation by injection of high-mobility group box 1 recovers post-infarction chronically failing heart
about
DAMPs from Cell Death to New LifeHMGB1 attenuates cardiac remodelling in the failing heart via enhanced cardiac regeneration and miR-206-mediated inhibition of TIMP-3HMGB1 loves companyCurrent Solutions for Long-Segment Tracheal Reconstruction.Novel HMGB1-inhibiting therapeutic agents for experimental sepsis.The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculatureHigh mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation.Siglec-G/10 in self-nonself discrimination of innate and adaptive immunity.Broad and direct interaction between TLR and Siglec families of pattern recognition receptors and its regulation by Neu1.Peroxynitrite induces HMGB1 release by cardiac cells in vitro and HMGB1 upregulation in the infarcted myocardium in vivo.HMGB1 in health and disease.Serum HMGB1 as a prognostic marker for malignant pleural mesotheliomaEmergence of dendritic cells in the myocardium after acute myocardial infarction - implications for inflammatory myocardial damage.Extracellular high mobility group box 1 plays a role in the effect of bone marrow mononuclear cell transplantation for heart failure.Exogenous high-mobility group box 1 protein injection improves cardiac function after myocardial infarction: involvement of Wnt signaling activation.Extracellular high-mobility group box 1 mediates pressure overload-induced cardiac hypertrophy and heart failure.Transcriptional profiling of HMGB1-induced myocardial repair identifies a key role for Notch signalingAttenuation of myocardial injury by HMGB1 blockade during ischemia/reperfusion is toll-like receptor 2-dependent.Toll-like receptors as potential therapeutic targets in cardiac dysfunction.Innate immune signaling in cardiac ischemia.The innate immune response in reperfused myocardium.Myocardial regeneration of the failing heart.Redox modulation of HMGB1-related signaling.Danger signals in the initiation of the inflammatory response after myocardial infarction.Myocyte signalling in leucocyte recruitment to the heart.Targeting danger-associated molecular patterns after myocardial infarction.The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.Systemic high-mobility group box 1 administration suppresses skin inflammation by inducing an accumulation of PDGFRα(+) mesenchymal cells from bone marrow.High mobility group box 1 protein attenuates myocardial ischemia reperfusion injury via inhibition of the p38 mitogen-activated protein kinase signaling pathway.Contrasting Inflammation Resolution during Atherosclerosis and Post Myocardial Infarction at the Level of Monocyte/Macrophage Phagocytic Clearance.Thrombomodulin's lectin-like domain reduces myocardial damage by interfering with HMGB1-mediated TLR2 signalling.Exogenous high-mobility group box 1 protein prevents postinfarction adverse myocardial remodeling through TGF-β/Smad signaling pathway.Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities.HMGB1 Inhibits Apoptosis Following MI and Induces Autophagy via mTORC1 Inhibition.The role of transient receptor potential vanilloid 2 channel in cardiac aging.HMGB1 gene polymorphism is associated with hypertension in Han Chinese population.Sodium Houttuyfonate Alleviates Post-infarct Remodeling in Rats via AMP-Activated Protein Kinase Pathway
P2860
Q26782785-92B62568-6529-4166-A34A-42F61E485F80Q27342035-4CA7EE0B-48E7-4328-BBB0-5F297F2EF5B9Q28243671-B4085422-7737-475F-A8E3-7B197E91FE15Q33650604-7879B72E-331B-4C06-AE13-AE88D0B9F64AQ33814903-1C422CF1-3F77-4748-A7B8-9F7C7B62D2D8Q33822512-84658EEF-9728-4941-BB4D-9F51F78EC251Q33836853-E1902C3C-69F4-4281-B475-43212634B651Q33974526-B45D2DDA-F7F8-4D52-A01D-F4C99622C74DQ34208916-FBC7AD6A-048D-495A-B581-A4DFC7EF534AQ34530243-177ED1D0-9545-49E2-9013-595A81FCBBC3Q34622835-A0EA1AB4-3896-4DBF-9E5B-58481590CFC1Q34687224-C8029598-70F3-4AA2-8EC0-D3C7B8FD1ED3Q34722498-80087258-E326-40B9-8E97-2DE01D5E8045Q35034878-0A45EAE8-E84A-4605-812F-0F664CA33918Q36000159-7AF2E9AD-7189-47C4-B882-E2A2B7EF2599Q36595286-578F3916-1227-47E0-A4CC-CFBBA0D949D1Q37254881-26E87105-B6DC-4789-8A92-D0108488ADAEQ37382986-78AD2591-C991-46BC-866B-644C6FF436BDQ37850809-8DF75FE0-04C6-4FF8-953E-81F423F3806CQ37859249-F3B521AD-4313-458C-9A54-40F466BDC425Q37977824-8315BCB3-C607-460B-AD70-9ECB680866B7Q38045804-F377B3AA-3954-4F51-8997-A91D8C0A766AQ38078441-41988487-84C4-4E56-8240-E0A30F6F16C8Q38173348-264D851E-591F-49BC-BD67-A0FA3FDBB703Q38185647-A023FA69-DD8E-4D17-A32F-648EB7246F0EQ38595544-861DA05D-7C23-48B8-90F5-9816C57F3086Q38875774-C9FAB203-9C74-4313-B40B-3E24798E36A5Q38998975-29068529-235B-4571-8833-92424633AA9FQ41113669-9631773C-79EB-4481-825F-D02562B3AF2BQ42144621-2A9AC962-B727-4572-B096-C41A995F46D0Q45858876-0248E5D6-13E9-4577-AC46-4B86E82C6F28Q46733988-4C56FD70-E136-4F6D-A80C-FAA5803679EBQ47734765-03A89526-6EAB-48F1-895B-E1C4CF858122Q51540453-456E901E-6CF5-4E40-81DA-03728567A594Q51736072-946B574C-BB7E-421C-99EC-69AD22A6D582Q54198044-59B1C2EF-A8A8-4032-B4D5-605E9E80131AQ57490976-80FED64C-8E04-4D15-A0CC-F825B680A2AF
P2860
Modulated inflammation by injection of high-mobility group box 1 recovers post-infarction chronically failing heart
description
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2008
@ast
im September 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2008/09/30)
@sk
vědecký článek publikovaný v roce 2008
@cs
wetenschappelijk artikel (gepubliceerd op 2008/09/30)
@nl
наукова стаття, опублікована у вересні 2008
@uk
مقالة علمية (نشرت في 30-9-2008)
@ar
name
Modulated inflammation by inje ...... tion chronically failing heart
@ast
Modulated inflammation by inje ...... tion chronically failing heart
@en
Modulated inflammation by inje ...... tion chronically failing heart
@nl
type
label
Modulated inflammation by inje ...... tion chronically failing heart
@ast
Modulated inflammation by inje ...... tion chronically failing heart
@en
Modulated inflammation by inje ...... tion chronically failing heart
@nl
prefLabel
Modulated inflammation by inje ...... tion chronically failing heart
@ast
Modulated inflammation by inje ...... tion chronically failing heart
@en
Modulated inflammation by inje ...... tion chronically failing heart
@nl
P2093
P1433
P1476
Modulated inflammation by inje ...... tion chronically failing heart
@en
P2093
Husein K. Salem
Ken Suzuki
Kenichi Yamahara
Kenta Yashiro
Kunihiko Takahashi
Magdi H. Yacoub
Satsuki Fukushima
Scott W. Brouilette
Steven R. Coppen
Yasunori Shintani
P304
P356
10.1161/CIRCULATIONAHA.107.757443
P407
P433
P577
2008-09-30T00:00:00Z